You have 9 free searches left this month | for more free features.

recurrence after a 1st line of hormone therapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Myrtle Beach (ChAdOx1-PCAQ, MVA-PCAQ)

Recruiting
  • Prostate Cancer
  • ChAdOx1-PCAQ
  • MVA-PCAQ
  • Myrtle Beach, South Carolina
    Carolina Urologic Research Center
Jan 30, 2023

Prostate Gland Cancer, Which Spreads to Other Parts of Body, Who

Completed
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Radium-223 (Xofigo, BAY88-8223)
  • +2 more
  • Whippany, New Jersey
    US Flatiron prostate cancer database
Dec 8, 2021

Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer

Recruiting
  • Lung Cancer Non-small Cell Stage IV
    • Athens, Greece
      Hellenic Cooperative Oncology Group
    Nov 14, 2022

    Recurrent Nasopharyngeal Carcinoma, Metastatic Nasopharyngeal Carcinoma, Chemo Effect Trial in Guangzhou (PD-1 Immune Checkpoint

    Active, not recruiting
    • Recurrent Nasopharyngeal Carcinoma
    • +2 more
    • PD-1 Immune Checkpoint Inhibitor Combined With Bevacizumab
    • Guangzhou, Guangdong, China
      Yanqun Xiang
    Sep 5, 2022

    Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract

    Recruiting
    • Biliary Tract Neoplasms
    • +3 more
    • Shanghai, China
      Huashan hospital
    Aug 16, 2022

    Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)

    Not yet recruiting
    • Advanced or Metastatic Breast Cancer
    • (no location specified)
    Oct 24, 2023

    Breast Cancer Metastatic Trial in Ravensburg (Ribociclib, Anastrozole, Letrozole)

    Active, not recruiting
    • Breast Cancer Metastatic
    • Ravensburg, Germany
      Studienzentrum Onkologie Ravensburg
    Mar 7, 2022

    Real-world Prescription Pattern of Palbociclib Combination

    Active, not recruiting
    • Metastatic Breast Cancer
    • Patients who received Palbociclib as first line therapy in MBC setting
    • Seoul, Korea, Republic of
      Pfizer Local Country Office
    Jun 28, 2022

    NSCLC NSCLC Trial in Pittsburgh, Dallas (durvalumab)

    Completed
    • Non-Small Cell Lung Cancer NSCLC
    • Pittsburgh, Pennsylvania
    • +1 more
    Aug 2, 2022

    Prostate Cancer, Ultrasound Therapy Trial in France, Guadeloupe (Radical Prostatectomy, High Intensity Focused Ultrasound (HIFU)

    Completed
    • Prostate Cancer
    • Ultrasound Therapy
    • Radical Prostatectomy
    • High Intensity Focused Ultrasound (HIFU) Treatment
    • Aix en Provence, France
    • +48 more
    Jan 11, 2023

    Atrial Fibrillation Trial in City Of London (Apple Watch-based heart rhythm monitoring)

    Recruiting
    • Atrial Fibrillation
    • Apple Watch-based heart rhythm monitoring
    • City Of London, London, United Kingdom
      St Bartholomew's Hospital
    Jul 19, 2022

    Prognosis of Low-grade Endometrial Stromal Sarcoma

    Recruiting
    • Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis)
    • +6 more
    • Surgical treatment with and without fertility-sparing procedures
    • Beijing, Beijing, China
      Lei Li
    Mar 26, 2022

    FIGO Stage III and IV Ovarian Cancer, FIGO Stage III and IV Fallopian Tube Cancer, FIGO Stage III Primary Peritoneal Cancer

    Completed
    • FIGO Stage III and IV Ovarian Cancer
    • +2 more
    • ALT-803 Subcutaneous
    • ALT-803 Intraperitoneal
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Oct 5, 2022

    HIV-1-infection Trial in Moscow, Saint-Petersburg (VM-1500A-LAI, Standard of Care)

    Not yet recruiting
    • HIV-1-infection
    • Moscow, Russian Federation
    • +1 more
    Jan 21, 2022

    Among Advanced Renal Cell Carcinoma Receiving Systemic

    Not yet recruiting
    • Carcinoma, Renal Cell
      • (no location specified)
      Sep 6, 2022

      Metastatic Castration-resistent Prostate Cancer Trial in Napoli (Docetaxel, Abiraterone Acetate or Enzalutamide)

      Active, not recruiting
      • Metastatic Castration-resistent Prostate Cancer
      • Napoli, Italy
        Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento
      Jul 27, 2021

      Recurrence After Emergency Presentation for Allergic REaction

      Recruiting
      • Anaphylaxis
      • Observational
      • Calgary, Alberta, Canada
      • +6 more
      Nov 1, 2022

      OSA Trial in London (CPAP withdrawal)

      Completed
      • OSA
      • CPAP withdrawal
      • London, United Kingdom
        Guys and St Thomas NHS Foundation Trust
      Mar 14, 2022

      Chronic Rhinosinusitis With Nasal Polyps Trial in Montreal (Dupilumab 300 MG in 2 ML Prefilled Syringe, Placebo, Mometasone

      Recruiting
      • Chronic Rhinosinusitis With Nasal Polyps
      • Dupilumab 300 MG in 2 ML Prefilled Syringe
      • +2 more
      • Montreal, Quebec, Canada
        Centre Hospitalier de l'Université de Montréal (CHUM)
      Nov 10, 2022

      Locally Advanced or Metastatic Renal Cell Carcinoma Trial in Worldwide (Cabozantinib)

      Active, not recruiting
      • Locally Advanced or Metastatic Renal Cell Carcinoma
      • Salzburg, Austria
      • +39 more
      Jan 18, 2023

      Hodgkin Lymphoma, Adult, Relapse, Refractory Hodgkin Lymphoma Trial in Tianjin (PD-1 inhibitor)

      Recruiting
      • Hodgkin Lymphoma, Adult
      • +2 more
      • PD-1 inhibitor
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Dec 14, 2021

      Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma Trial in

      Active, not recruiting
      • Anatomic Stage IIIB Breast Cancer AJCC v8
      • +4 more
      • Pembrolizumab
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 30, 2022

      Breast Cancer Trial in Canton (TTI-101, Palbociclib, Aromatase inhibitor (AI))

      Recruiting
      • Breast Cancer
      • Saint Louis, Missouri
      • +2 more
      Jan 12, 2023

      Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Germany (Irinotecan Liposomal Injection [Onivyde])

      Active, not recruiting
      • Locally Advanced Pancreatic Cancer
      • Metastatic Pancreatic Cancer
      • Irinotecan Liposomal Injection [Onivyde]
      • Amberg, Germany
      • +34 more
      Aug 3, 2021

      Metastatic Colorectal Cancer Trial in Mecca (Panitumumab)

      Recruiting
      • Metastatic Colorectal Cancer
      • Mecca, Makkah Western, Saudi Arabia
        King Abdullah Medical City, Holy Capital
      Apr 5, 2022